Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Treasury Shares (2019 - 2025)

AVITA Medical filings provide 7 years of Treasury Shares readings, the most recent being $67048.0 for Q4 2025.

  • On a quarterly basis, Treasury Shares fell 42.79% to $67048.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $67048.0, a 42.79% decrease, with the full-year FY2025 number at $67048.0, down 42.79% from a year prior.
  • Treasury Shares hit $67048.0 in Q4 2025 for AVITA Medical, roughly flat from $67048.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $461496.0 in Q3 2022 to a low of $67048.0 in Q3 2025.
  • Median Treasury Shares over the past 5 years was $214269.0 (2024), compared with a mean of $220079.2.
  • Biggest five-year swings in Treasury Shares: tumbled 70.53% in 2021 and later surged 190.69% in 2022.
  • AVITA Medical's Treasury Shares stood at $297490.0 in 2021, then surged by 54.8% to $460518.0 in 2022, then plummeted by 48.94% to $235132.0 in 2023, then crashed by 50.16% to $117196.0 in 2024, then crashed by 42.79% to $67048.0 in 2025.
  • The last three reported values for Treasury Shares were $67048.0 (Q4 2025), $67048.0 (Q3 2025), and $99504.0 (Q2 2025) per Business Quant data.